Angiotensin II receptor blockade: a novel strategy to prevent immunosuppressant-associated cancer progression

Transplant Proc. 2001 Feb-Mar;33(1-2):1820-1. doi: 10.1016/s0041-1345(00)02696-8.

Authors

M Maluccio¹, V Sharma, M Lagman, G Konijn, M Suthanthiran

Affiliation

¹ Division of Nephrology, Department of Transplantation and Extracorporeal Therapy, New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York, USA.

PMID: 11267528
DOI: 10.1016/s0041-1345(00)02696-8

No abstract available

MeSH terms

Angiotensin Receptor Antagonists*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Animals
Carcinoma, Renal Cell / prevention & control*
Carcinoma, Renal Cell / secondary
Cyclosporine / adverse effects*
Immunosuppressive Agents / adverse effects*
Losartan / therapeutic use*
Lung Neoplasms / prevention & control*
Lung Neoplasms / secondary
Mice
Mice, Inbred BALB C
Mice, Inbred Strains
Mice, SCID

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Immunosuppressive Agents
Cyclosporine
Losartan